10/18/22 JAK Inhibitors vs Biologics for Atopic Dermatitis
Andrew Blauvelt, M.D., M.B.A., President, Oregon Medical Research Center
▶︎
Choosing the Right Path: JAK Inhibitors or Biologics for Atopic Dermatitis?
▶︎
Atopic Dermatitis: JAK Inhibitors and Beyond
▶︎
The Pathogenesis of Inflammatory Dermatologic Disorders and Rationale for Targeted Biologic Therapy
▶︎
Practical Symposium | JAK Inhibitor Therapy for Dermatologic Disorders by Neal Bhatia, MD
▶︎
How to understand native speakers when they talk quickly: Live English Class
▶︎
America Innovates Hosted by Forbes and America250 - Day 1
▶︎
Tracking severe thunderstorms, 5/19
▶︎
12/17/2024 Update on Atopic Dermatitis
▶︎
Dr. Thomas Mather a.k.a The TickGuy Shares Tick Prevention Tips | The Daily Show
▶︎
PASS Your Phlebotomy Exam! 💉 Must-Know Terms + Practice Questions
▶︎
SpaceX Starlink 17-42 Launch from SLC-4E Vandenberg, California
▶︎
Ask Brian Greene LIVE Q&A | World Science Festival
▶︎
🩸 Phlebotomy Technician Practice Quiz – with Nurse Eunice! 🎯
▶︎
Week 16 recap and MNF preview | Fantasy Focus Live!
▶︎
One final test before Starship Flight 12? - Countdown to Launch
▶︎
Webinar: Face the Facts—All About Facial Eczema
▶︎
ACLS Drugs Review with Nurse Eunice 📚💉
▶︎
IDEF Educational Series Webinar A Once Daily Oral JAK Inhibitor for Adults With Moderate to Severe
▶︎
Using Biologics to Manage Moderate to Severe Atopic Dermatitis
▶︎